Drug Database
Back to search

Finland· FI-REL-REL53473

Spravato

A esketamine product containing esketamine hydrochloride, registered in Finland by Janssen-Cilag International NV. The same ATC class is registered in 11 of our 19 countries.

ATC N06AX27

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedSpravatoATCN06AX27REGISTER NO.FI-REL-REL53473PACKS LISTED0CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about esketamine hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Esketamine is registered in 11 of 19 countries.

Countries holding a registration under ATC N06AX27 (esketamine), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 7 of them publish a price we can compare per daily dose
Search esketamine products by name

Esketamine · ATC N06AX27

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of esketamine costs, country by country.

Normalised to the WHO defined daily dose (8 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Esketamine · price per daily dose (8 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$66.47
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Fimea (Finland)
Active substance
Esketamine hydrochloride
Manufacturer
Janssen-Cilag International NV
Country
Finland (FI)
ATC code
N06AX27
ATC class
Esketamine
Defined daily dose
8 mg, N
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

91 interactions on record for esketamine.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check esketamine against other medicinesHow interaction checks work

Esketamine · interactions on record

91 records

  • 7 severe
  • 84 moderate

Most severe, free to view

  • PhentermineA08AA01severe
  • FenfluramineA08AA02severe
  • MazindolA08AA05severe
  • FenfluramineN03AX26severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Esketamine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All esketamine products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Austria · Escetex, Eskelan
  • Belgium · Esketamine Kalceks, Vesierra
  • Germany · Esketamin, Esketamin Inresa
  • Denmark · Esketamine Orifarm, S-Ketamin Pfizer
  • Estonia · Esketex
  • France · Eskesia, Esketamine Renaudin
  • United Kingdom (Northern Ireland) · Esketamine Idd, Esketamine Kalceks
  • Croatia · Esgamda
  • Iceland · S-Ketamin Pfizer, Spravato
  • Liechtenstein · Spravato
  • Luxembourg · Vesierra
  • Latvia · Esketamine Kalceks
  • Netherlands · Esketamine Focus, Esketamine Idd
  • Norway · Ketanest, Sinmelan
  • Sweden · Esketamine Kalceks, Esketamine Orifarm
  • Slovenia · Esketamin Kalceks, Sinmelan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cab8f0db-15e6-40e3-ad83-889957175a17
GET /v1/drugs/cab8f0db-15e6-40e3-ad83-889957175a17?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "8",
  "form": "nenäsumute, liuos",
  "route": "Nenään",
  "ddd_unit": "mg",
  "strength": "28 mg",
  "atc_label": "esketamiini",
  "ma_number": null,
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": "EU/1/19/1410/001-006",
  "fimea_rel_id": "REL53473",
  "authorised_at": "2019-12-18"
}
API referenceMCP serverPlans

See everything about esketamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console